A A A

F F F

C C C

Introduction Alphabetic List Types of Intervention

Assistive and Adaptive Technology Augmentative and Alternative Communication Behavioural and Developmental Biomedical Interventions Complementary and Alternative Medicine Diets and Supplements Educational Interventions Medical Procedures Medications

Central Nervous System Medications Cardiovascular and Respiratory Medications Endocrine System Medications Immunology and Infection Medications Antipsychotics

Aripiprazole Haloperidol Olanzapine Risperidone Other Antipsychotics

Motor Sensory Interventions Parent Training and Support Psychological Interventions Social Care Standard Health Care Vocational Interventions Other Interventions

Our Evaluations Harmful Interventions Making the Decision Other Aspects

Aripiprazole and Autism

Aripiprazole is a type of atypical antipsychotic medication sold under the brand names Abilify and Aripiprex.

It works by changing the activity of dopamine and other neurotransmitters in the brain and is used to treat the symptoms of schizophrenia, bipolar disorder and depression.

It is sometimes used to treat problem behaviours in people on the autism spectrum, including hyperactivity, aggression, and restricted, repetitive patterns of behaviour, interests, or activities.

Related Glossaries

Aripiprazole

Related Publications

Blankenship K. et al. (2010) Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years. Pediatric Health. 4(4), Read Abstract (New Window) Read Full (New Window)
Ching H., Pringsheim T. (2012) Aripiprazole for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews. Read Abstract (New Window) Read Full (New Window)
Curran M. (2011) Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients. Pediatric Drugs. 13(3), Read Abstract (New Window)
Deb S. et al. (2014) The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder: A systematic review. Research in Developmental Disabilities. 35(3), Read Abstract (New Window)
Erickson C. A. et al. (2010) Aripiprazole in autism spectrum disorders and fragile X syndrome. Neurotherapeutics. 7(3), Read Abstract (New Window)
Farmer C. A., Aman M. G. (2011) Aripiprazole for the treatment of irritability associated with autism. Expert Opinion on Pharmacotherapy. 12(4), Read Abstract (New Window)
Findling R. L. et al. (2014) A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder. Journal of Clinical Psychiatry. 75(1), Read Abstract (New Window)
Kim Y. et al. (2010) Retrospective case series of aripiprazole augmentation in pervasive developmental disorders. Psychiatry Investigations. 7(3), Read Full (New Window)
Marcus R. N. et al. (2009) A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 48(11), Read Abstract (New Window)
Marcus R. N. et al. (2011) Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study. Journal of Child and Adolescent Psychopharmacology. 21(3), Read Abstract (New Window)

Quick link:: https://www.informationautism.org/aripiprazole

Updated: 18 Jun 2018

Rate This Page

Poor | Satisfactory | Good | Excellent

Print This Page / view All

Information Autism service, part of the John and Lorna Wing Foundation.

Registered as a charity in England and Wales (1156443). © The John and Lorna Wing Foundation 2021.